Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Tuberculosis

Explore clinical trials studying Pulmonary Tuberculosis. Study availability and eligibility vary by location and protocol.

79 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Tuberculosis trial results

Completed

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

NCT01498419

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations
  • Task Applied Science, Karl Bremer Hospital Cape Town, South Africa
  • University of Cape Town Lung Institute (Pty) Ltd Cape Town, South Africa
  • KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) Durban, South Africa
  • CHRU Themba Lethu Clinic Johannesburg, South Africa
View Trial Details
Completed

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis

NCT00864383

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +9 more
Locations
  • Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing, China
  • Shanghai Pulmonary Hospital Shanghai, China
  • TB Institute Tianjin, China
  • Nirmal Kumar Jain Jaipur, Rajasthan, India
View all 47 locations
View Trial Details

Related conditions